RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Richard Yanagihara to Mucocutaneous Lymph Node Syndrome

This is a "connection" page, showing publications Richard Yanagihara has written about Mucocutaneous Lymph Node Syndrome.
  1. Chua PK, Nerurkar VR, Yu Q, Woodward CL, Melish ME, Yanagihara R. Lack of association between Kawasaki syndrome and infection with parvovirus B19, human herpesvirus 8, TT virus, GB virus C/hepatitis G virus or Chlamydia pneumoniae. Pediatr Infect Dis J. 2000 May; 19(5):477-9.
    View in: PubMed
    Score: 0.181
  2. Chua PK, Yanagihara R, Melish ME, Nerurkar VR. Modulation of adhesion molecules and monocyte chemoattractant protein by tumor necrosis factor-alpha and salicylic acid in primary human coronary artery endothelial cells. Cell Mol Biol (Noisy-le-grand). 2003 Nov; 49(7):1157-66.
    View in: PubMed
    Score: 0.058
  3. Chua PK, Melish ME, Yu Q, Yanagihara R, Yamamoto KS, Nerurkar VR. Elevated levels of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 during the acute phase of Kawasaki disease. Clin Diagn Lab Immunol. 2003 Mar; 10(2):308-14.
    View in: PubMed
    Score: 0.055
  4. Yanagihara R, Todd JK. Acute febrile mucocutaneous lymph node syndrome. Am J Dis Child. 1980 Jun; 134(6):603-14.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support